Main menu

Population-based nanopore sequencing of the HIV-1 pangenome to identify drug resistance mutations


HIV-1 drug resistance testing now requires the analysis of multiple segmented genes, meaning that traditional Sanger sequencing is no longer sufficient. Here the authors use nanopore sequencing to construct near-full-length HIV-1 genomes, allowing for comparable detection of drug resistance to Sanger sequencing. As their method is simpler and more comprehensive, the authors suggest that it could be used in clinical settings globally.

Authors: Hirotaka Ode, Masakazu Matsuda, Urara Shigemi, Mikiko Mori, Yoshimi Yamamura, Yoshihiro Nakata, Reiko Okazaki, Mai Kubota, Yuka Setoyama, Mayumi Imahashi, Yoshiyuki Yokomaku, Yasumasa Iwatani

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag